Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Shares of SAP fell sharply after Oracle revealed fiscal 2027 capital expenditure plans that significantly exceeded analyst expectations. Oracle said it could spend as much as $95 billion, with up to $25 billion expected to be recovered from customers, and plans to raise nearly $40 billion through a mix of debt and equity financing. The disclosure h…
Leaders of the Group of Seven will meet in Evian-les-Bains on June 15-17 with urgent crises in the Middle East and Ukraine shaping the agenda. Host France has narrowed expectations and tailored topics to avoid direct confrontation with U.S. President Donald Trump, while inviting regional actors and Ukraine to engage on fragile ceasefire talks, sanc…
Halma PLC's shares plunged around 12% after the group's full-year results for the year ended March 31, 2026 prompted a pronounced sell-the-news reaction. While revenue and adjusted EBIT beat analyst forecasts and the board increased the dividend by 7%, investors latched onto rising customer concentration in the photonics business, a sizable slowdow…
Bank of Japan Governor Kazuo Ueda's two-week hospitalisation removes the visible anchor from a critical June policy meeting and could complicate communications as the BOJ moves toward further rate increases. While officials and analysts say the upcoming rate decision is settled and Ueda is expected to continue duties remotely and return in July, hi…
Oculis Holding AG announced it will present the development and clinical progress of Privosegtor, a novel peptoid small molecule targeting optic neuritis and other optic neuropathies, at the Clinical Trials at the Summit 2026. Privosegtor has shown positive Phase 2 trial results and has received Breakthrough Therapy and PRIME designations from FDA …
The U.S. State Department confirmed the death of a U.S. government employee assigned to its embassy in Yangon. The official was discovered at the Sakura Residence & Hotel in the city’s diplomatic district, and a Thai national was reported detained in connection with the incident. Local authorities and hotel staff have declined comment while consula…
Camurus AB shares fell sharply after the U.S. Food and Drug Administration issued a Complete Response Letter for Oclaiz (CAM2029) on the PDUFA action date. The agency cited manufacturing observations at a third-party facility and requested a minor labeling change, rather than raising clinical safety or efficacy concerns. Jefferies now expects U.S. …
Oracle shares plunged deeply in after-hours trading following its Q4 FY2026 results as investors reacted to a massive jump in capital expenditures and a newly disclosed plan to raise roughly $40 billion to fund an accelerated AI data center buildout. Despite revenue growth and an earnings beat, negative free cash flow, guidance at the low end of ex…
Vestum AB (publ) shares rallied sharply after the company agreed to sell its Flow Technology business to Nordic Capital for SEK 6.5 billion on a cash- and debt-free basis. The fully financed deal, expected to close in the second half of 2026 pending approvals, is projected to yield a capital gain of about SEK 3.5 billion and prompted the board to s…
Ford is issuing a recall for 548,463 vehicles in the United States after the National Highway Traffic Safety Administration said chrome plating on the center console can bubble and peel, potentially producing sharp edges that raise the risk of passenger injury. The recall covers certain 2018-2024 Ford Expedition models; the regulator said the affec…
Elon Musk is scheduled to appear virtually at ASML's annual one-day technology conference to outline Terafab, his planned large-scale chipmaking initiative intended to supply Tesla and SpaceX. The appearance comes ahead of expected pricing for SpaceX's initial public offering later Thursday. ASML confirmed Musk will discuss AI, robotics, space and …
M&C Saatchi reported that its results for the first four months of the year aligned with market expectations, driven by growth in its high-margin Issues and Media divisions. The British advertising group said like-for-like net revenue for the period supports the market's full-year outlook, even as clients pare non-essential marketing spend amid mac…
Shares of Hugo Boss climbed sharply after Britain’s Frasers Group tabled a cash offer of €38 per share for the German fashion house’s remaining equity, valuing the portion it does not own at about €1.98 billion ($2.3 billion). The company said the approach was not coordinated with management and that the board will examine the proposal. Market reac…
Camurus shares fell 7% after the U.S. Food and Drug Administration rejected the company's application for Oclaiz, an acromegaly treatment. The FDA requested a reinspection of a third-party manufacturing site and a minor labeling revision. Industry analysts say the setback is a near-term negative but does not alter the drug's clinical profile or Cam…
Vestum announced the sale of its stake in Flowa Technology to private equity firm Nordic Capital for 6.5 billion crowns on a cash- and debt-free basis. The deal, fully financed by Nordic Capital, is expected to close in the second half of 2026 subject to regulatory approvals and customary conditions. Vestum said the divestment will likely produce a…
Figeac Aéro reported record revenue of €486.8 million and current EBITDA of €78.6 million for the 2025/26 year ended March 31, 2026, meeting all its financial targets for the fifth consecutive year. Organic revenue grew 15.8%, current EBITDA rose 13.1%, and free cash flow of €36.0 million fell within the company's target range. Net debt decreased, …
European stocks moved modestly higher in choppy trade as investors balanced rising Middle East tensions and firm oil prices against positive corporate updates and gains in semiconductor names. Attention is set on the European Central Bank’s policy decision later in the day, with markets pricing a 25-basis-point hike and watching how an oil-driven s…
China’s recent enforcement against cross-border investment channels and the punishment of three online brokers for allegedly facilitating overseas share purchases has raised immediate caution among Hong Kong financial firms and their mainland clients. The move threatens revenue streams from insurance sales, wealth management products and stock deal…
Melker Schörling AB (MSAB) has purchased all outstanding A-shares in Beijer Ref AB from EQT and Peter Jessen Jürgensen for an undisclosed premium, giving MSAB 14.1% of voting rights and 2.1% of share capital. MSAB intends to gradually increase its holding and has entered a mutual right of first refusal agreement with Per Bertland. The deal maintain…
Frasers Group has tabled a voluntary public takeover bid for the roughly 74% of Hugo Boss it does not already own, proposing €38 in cash per share. The offer values Hugo Boss’s equity at about €2.7 billion and carries a modest 4% premium to the company’s recent close. Frasers said the move is aimed at facilitating further investment, and the German…
Intertek has agreed to extend the deadline for EQT to declare a firm intention on its conditional takeover proposal to 5:00 pm on June 18, 2026. The private equity suitor has confirmed the proposed cash price remains £60.00 per share while Intertek retains the right to pay an approved final dividend for 2025 without reducing the offer amount.
British equities showed resilience on Thursday, with the FTSE 100 recording a modest gain even as the region experienced another round of US strikes on Iran and Iranian missile responses. Markets were also focused on a European Central Bank interest rate decision due later in the day, while commodity prices and individual UK corporate moves reflect…
IDEAYA's darovasertib Phase 2/3 readout (darovasertib + crizotinib) delivered materially better PFS and ORR versus standard therapy, and management plans an NDA submission in H2 2026. With ~ $2.45B market cap, a healthy cash cushion and elevated short interest, IDYA is a high-conviction long for traders who can tolerate binary regulatory risk. This…
Hugo Boss shares climbed after Frasers Group plc submitted an unsolicited voluntary cash takeover offer of €38.00 per share, valuing the company at about €1.978 billion. The proposal, which was published after the previous session closed, surprised Hugo Boss’s management and has created a near-term valuation floor while investors await the board's …
Wizz Air Holdings PLC saw its shares rise after reporting full-year results that significantly surpassed analyst forecasts. The ultra-low-cost carrier posted an operating profit of €139.7 million for the year to March 31, 2026, well above a consensus of €88.5 million, while revenue, available seat kilometres and seats flown all expanded versus the …
